In a meta-analysis that looked at almost 900 breast cancer cases compared to over 1800 control samples, Zhou et al. (2010) found that ALDH1A1 expression was significantly associated with a high histological grade, ER/PR negativity, HER2 positivity, and worse overall survival [25]. This evidence concerns the gene ALDH1A1 and breast carcinoma.